Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONGeneric

CHYMODIACTIN

CHYMOPAPAIN

Standard Dose
10,000 UNITS/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary

Approval overview CHYMODIACTIN is listed in Drugs@FDA under application 018663 (BLA).

Review priority: PRIORITY Marketing status: Discontinued Active ingredient CHYMOPAPAIN Form and strength INJECTABLE;INJECTION - 10,000 UNITS/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** Sponsor DISCURE MEDICAL, LLC Submission history Latest submission status date: 1994-10-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview CHYMODIACTIN is listed in Drugs@FDA under application 018663 (BLA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient CHYMOPAPAIN Form and strength INJECTABLE;INJECTION - 10,000 UNITS/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** Sponsor DISCURE MEDICAL, LLC Submission history Latest submission status date: 1994-10-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.
CHYMODIACTIN (CHYMOPAPAIN) | Drug Monograph | MedicHelpline